Dogwood Therapeutics (DWTX) Competitors $3.15 +1.28 (+68.45%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends DWTX vs. CSCI, TXMD, RLMD, ACXP, CLDI, APLM, CLRB, BCLI, TSBX, and JAGXShould you be buying Dogwood Therapeutics stock or one of its competitors? The main competitors of Dogwood Therapeutics include COSCIENS Biopharma (CSCI), TherapeuticsMD (TXMD), Relmada Therapeutics (RLMD), Acurx Pharmaceuticals (ACXP), Calidi Biotherapeutics (CLDI), Apollomics (APLM), Cellectar Biosciences (CLRB), Brainstorm Cell Therapeutics (BCLI), Turnstone Biologics (TSBX), and Jaguar Health (JAGX). These companies are all part of the "pharmaceutical products" industry. Dogwood Therapeutics vs. COSCIENS Biopharma TherapeuticsMD Relmada Therapeutics Acurx Pharmaceuticals Calidi Biotherapeutics Apollomics Cellectar Biosciences Brainstorm Cell Therapeutics Turnstone Biologics Jaguar Health COSCIENS Biopharma (NASDAQ:CSCI) and Dogwood Therapeutics (NASDAQ:DWTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings. Does the media refer more to CSCI or DWTX? In the previous week, Dogwood Therapeutics had 1 more articles in the media than COSCIENS Biopharma. MarketBeat recorded 1 mentions for Dogwood Therapeutics and 0 mentions for COSCIENS Biopharma. COSCIENS Biopharma's average media sentiment score of 0.00 beat Dogwood Therapeutics' score of -0.76 indicating that COSCIENS Biopharma is being referred to more favorably in the media. Company Overall Sentiment COSCIENS Biopharma Neutral Dogwood Therapeutics Negative Which has more risk & volatility, CSCI or DWTX? COSCIENS Biopharma has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Comparatively, Dogwood Therapeutics has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Which has preferable valuation and earnings, CSCI or DWTX? Dogwood Therapeutics has lower revenue, but higher earnings than COSCIENS Biopharma. Dogwood Therapeutics is trading at a lower price-to-earnings ratio than COSCIENS Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCOSCIENS Biopharma$4.50M2.46-$16.55M-$11.87-0.25Dogwood TherapeuticsN/AN/A-$5.30M-$6.55-0.48 Does the MarketBeat Community prefer CSCI or DWTX? COSCIENS Biopharma and Dogwood Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCOSCIENS BiopharmaN/AN/ADogwood TherapeuticsN/AN/A Is CSCI or DWTX more profitable? Dogwood Therapeutics has a net margin of 0.00% compared to COSCIENS Biopharma's net margin of -428.43%. COSCIENS Biopharma's return on equity of -95.93% beat Dogwood Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets COSCIENS Biopharma-428.43% -95.93% -45.66% Dogwood Therapeutics N/A -217.12%-172.06% Do institutionals and insiders have more ownership in CSCI or DWTX? 0.7% of COSCIENS Biopharma shares are held by institutional investors. Comparatively, 9.1% of Dogwood Therapeutics shares are held by institutional investors. 0.1% of COSCIENS Biopharma shares are held by company insiders. Comparatively, 12.2% of Dogwood Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryCOSCIENS Biopharma and Dogwood Therapeutics tied by winning 6 of the 12 factors compared between the two stocks. Get Dogwood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DWTX vs. The Competition Export to ExcelMetricDogwood TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.19M$6.58B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E Ratio-0.4810.0188.8317.53Price / SalesN/A335.371,284.8780.48Price / CashN/A22.6336.6032.90Price / Book0.645.084.964.69Net Income-$5.30M$154.90M$117.89M$224.57M7 Day Performance41.26%2.59%2.75%3.33%1 Month Performance34.62%1.52%3.63%5.33%1 Year PerformanceN/A5.50%27.26%22.98% Dogwood Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DWTXDogwood TherapeuticsN/A$3.15+68.4%N/AN/A$4.19MN/A-0.485News CoverageGap UpHigh Trading VolumeCSCICOSCIENS BiopharmaN/A$3.28-3.5%N/AN/A$12.33M$7.60M-0.2820Gap UpTXMDTherapeuticsMD0.5973 of 5 stars$1.05-4.9%N/A-52.5%$12.06M$1.60M0.00420RLMDRelmada Therapeutics4.0617 of 5 stars$0.40-3.2%$4.25+965.2%-89.1%$12.04MN/A-0.1410ACXPAcurx Pharmaceuticals3.033 of 5 stars$0.70-13.0%$12.00+1,607.0%-76.1%$11.99MN/A-0.653Short Interest ↓CLDICalidi Biotherapeutics3.0568 of 5 stars$0.91-0.8%$16.67+1,735.7%N/A$11.87M$50,000.000.0038APLMApollomics2.3923 of 5 stars$10.74+1.9%$200.00+1,763.1%-89.3%$11.67M$1.22M0.0045CLRBCellectar Biosciences2.8355 of 5 stars$0.28-0.3%$17.67+6,178.1%-93.0%$11.61MN/A-0.1610Analyst ForecastHigh Trading VolumeBCLIBrainstorm Cell Therapeutics4.2346 of 5 stars$2.00-1.0%$30.00+1,400.0%-55.1%$11.35MN/A-0.4140Analyst UpgradeNews CoverageGap UpTSBXTurnstone Biologics3.0688 of 5 stars$0.480.0%$2.13+342.7%-77.0%$11.10M$19.31M-0.1582News CoverageJAGXJaguar Health0.5404 of 5 stars$0.93-6.8%N/A-86.1%$11.00M$10.48M0.0050 Related Companies and Tools Related Companies CSCI Alternatives TXMD Alternatives RLMD Alternatives ACXP Alternatives CLDI Alternatives APLM Alternatives CLRB Alternatives BCLI Alternatives TSBX Alternatives JAGX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DWTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DWTX Stock Alerts